Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Baruch

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Postgraduate Medicine|July 3, 2013
Laboratory monitoring of anticoagulant medications: focus on novel oral anticoagulantsLawrence Baruch
Journal of Clinical Hypertension (Greenwich, Conn.)|May 11, 2004
Hypertension and the elderly: more than just blood pressure controlLawrence Baruch
The Annals of Pharmacotherapy|June 30, 2011
Potential inaccuracy of point-of-care INR in dabigatran-treated patientsLawrence Baruch, Olga Sherman
Current Heart Failure Reports|July 23, 2005
Beta-blockers in heart failure: is more better?Lawrence Baruch, Prabhakara Kunamneni
The Annals of Pharmacotherapy|November 22, 2013
Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patientsLawrence Baruch, Olga Sherman
Archives of Internal Medicine|July 13, 2005
Quality: the need for intelligent effortsLawrence Baruch, Robert A Phillips
The American Journal of Medicine|February 7, 2012
Interpretation of point-of-care INR results in patients treated with dabigatranJoanne van Ryn, Lawrence Baruch, Andreas Clemens
Cholesterol|May 28, 2013
Discordance of Non-HDL and Directly Measured LDL Cholesterol: Which Lipid Measure is Preferred When Calculated LDL Is Inaccurate?Lawrence Baruch, Valerie J Chiong, Sanjay Agarwal, et al.
The American Journal of Cardiology|May 26, 2009
Effect on serum lipid levels of switching dose of ezetimibe from 10 to 5 mgLawrence Baruch, Sanjay Agarwal, Bhanu Gupta, et al.
The American Journal of Managed Care|October 8, 2008
Ezetimibe 5 and 10 mg for lowering LDL-C: potential billion-dollar savings with improved tolerabilityLawrence Baruch, Bhanu Gupta, Sharon S Lieberman-Blum, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Postgraduate Medicine|July 3, 2013
Laboratory monitoring of anticoagulant medications: focus on novel oral anticoagulantsLawrence Baruch
Journal of Clinical Hypertension (Greenwich, Conn.)|May 11, 2004
Hypertension and the elderly: more than just blood pressure controlLawrence Baruch
The Annals of Pharmacotherapy|June 30, 2011
Potential inaccuracy of point-of-care INR in dabigatran-treated patientsLawrence Baruch, Olga Sherman
Current Heart Failure Reports|July 23, 2005
Beta-blockers in heart failure: is more better?Lawrence Baruch, Prabhakara Kunamneni
The Annals of Pharmacotherapy|November 22, 2013
Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patientsLawrence Baruch, Olga Sherman
Archives of Internal Medicine|July 13, 2005
Quality: the need for intelligent effortsLawrence Baruch, Robert A Phillips
The American Journal of Medicine|February 7, 2012
Interpretation of point-of-care INR results in patients treated with dabigatranJoanne van Ryn, Lawrence Baruch, Andreas Clemens
Cholesterol|May 28, 2013
Discordance of Non-HDL and Directly Measured LDL Cholesterol: Which Lipid Measure is Preferred When Calculated LDL Is Inaccurate?Lawrence Baruch, Valerie J Chiong, Sanjay Agarwal, et al.
The American Journal of Cardiology|May 26, 2009
Effect on serum lipid levels of switching dose of ezetimibe from 10 to 5 mgLawrence Baruch, Sanjay Agarwal, Bhanu Gupta, et al.
The American Journal of Managed Care|October 8, 2008
Ezetimibe 5 and 10 mg for lowering LDL-C: potential billion-dollar savings with improved tolerabilityLawrence Baruch, Bhanu Gupta, Sharon S Lieberman-Blum, et al.
Pageof 2